nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ACE—prostate cancer	0.383	1	CbGaD
Perindopril—ABCB1—Estramustine—prostate cancer	0.053	0.2	CbGbCtD
Perindopril—ABCB1—Cabazitaxel—prostate cancer	0.035	0.132	CbGbCtD
Perindopril—ABCB1—Estrone—prostate cancer	0.0342	0.129	CbGbCtD
Perindopril—ABCB1—Ethinyl Estradiol—prostate cancer	0.0305	0.115	CbGbCtD
Perindopril—ABCB1—Conjugated Estrogens—prostate cancer	0.0224	0.0843	CbGbCtD
Perindopril—ABCB1—Mitoxantrone—prostate cancer	0.0203	0.0767	CbGbCtD
Perindopril—ABCB1—Estradiol—prostate cancer	0.0196	0.074	CbGbCtD
Perindopril—ABCB1—Prednisone—prostate cancer	0.0169	0.0637	CbGbCtD
Perindopril—ABCB1—Etoposide—prostate cancer	0.0128	0.0483	CbGbCtD
Perindopril—ABCB1—Docetaxel—prostate cancer	0.0117	0.0442	CbGbCtD
Perindopril—ABCB1—Doxorubicin—prostate cancer	0.00874	0.033	CbGbCtD
Perindopril—ACE—urine—prostate cancer	0.00538	0.159	CbGeAlD
Perindopril—SLC15A1—epithelium—prostate cancer	0.00198	0.0584	CbGeAlD
Perindopril—ACE—prostate gland—prostate cancer	0.00193	0.057	CbGeAlD
Perindopril—SLC15A1—renal system—prostate cancer	0.00184	0.0542	CbGeAlD
Perindopril—SLC15A2—prostate gland—prostate cancer	0.00168	0.0497	CbGeAlD
Perindopril—ACE—seminal vesicle—prostate cancer	0.00163	0.0482	CbGeAlD
Perindopril—BCHE—prostate gland—prostate cancer	0.00143	0.0421	CbGeAlD
Perindopril—SLC15A2—seminal vesicle—prostate cancer	0.00142	0.042	CbGeAlD
Perindopril—ACE—epithelium—prostate cancer	0.00142	0.0419	CbGeAlD
Perindopril—ACE—renal system—prostate cancer	0.00132	0.0388	CbGeAlD
Perindopril—ACE—urethra—prostate cancer	0.00129	0.0381	CbGeAlD
Perindopril—BCHE—seminal vesicle—prostate cancer	0.00121	0.0356	CbGeAlD
Perindopril—SLC15A2—renal system—prostate cancer	0.00115	0.0339	CbGeAlD
Perindopril—SLC15A2—urethra—prostate cancer	0.00113	0.0333	CbGeAlD
Perindopril—ACE—bone marrow—prostate cancer	0.000995	0.0294	CbGeAlD
Perindopril—ACE—testis—prostate cancer	0.000851	0.0251	CbGeAlD
Perindopril—SLC15A2—testis—prostate cancer	0.000742	0.0219	CbGeAlD
Perindopril—BCHE—bone marrow—prostate cancer	0.000735	0.0217	CbGeAlD
Perindopril—ABCB1—prostate gland—prostate cancer	0.00068	0.0201	CbGeAlD
Perindopril—BCHE—testis—prostate cancer	0.000628	0.0185	CbGeAlD
Perindopril—ACE—lymph node—prostate cancer	0.000617	0.0182	CbGeAlD
Perindopril—Spirapril—ACE—prostate cancer	0.000606	0.156	CrCbGaD
Perindopril—Moexipril—ACE—prostate cancer	0.000581	0.149	CrCbGaD
Perindopril—ABCB1—seminal vesicle—prostate cancer	0.000575	0.017	CbGeAlD
Perindopril—Quinapril—ACE—prostate cancer	0.00054	0.139	CrCbGaD
Perindopril—Cilazapril—ACE—prostate cancer	0.00054	0.139	CrCbGaD
Perindopril—SLC15A2—lymph node—prostate cancer	0.000538	0.0159	CbGeAlD
Perindopril—Ramipril—ACE—prostate cancer	0.000523	0.134	CrCbGaD
Perindopril—Trandolapril—ACE—prostate cancer	0.000523	0.134	CrCbGaD
Perindopril—ABCB1—epithelium—prostate cancer	0.0005	0.0147	CbGeAlD
Perindopril—ABCB1—renal system—prostate cancer	0.000463	0.0137	CbGeAlD
Perindopril—BCHE—lymph node—prostate cancer	0.000455	0.0134	CbGeAlD
Perindopril—ABCB1—urethra—prostate cancer	0.000455	0.0134	CbGeAlD
Perindopril—Enalapril—ACE—prostate cancer	0.000397	0.102	CrCbGaD
Perindopril—ABCB1—bone marrow—prostate cancer	0.00035	0.0103	CbGeAlD
Perindopril—ABCB1—testis—prostate cancer	0.000299	0.00883	CbGeAlD
Perindopril—ABCB1—lymph node—prostate cancer	0.000217	0.0064	CbGeAlD
Perindopril—Enalapril—CYP3A4—prostate cancer	0.000186	0.0478	CrCbGaD
Perindopril—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.77e-05	0.000184	CcSEcCtD
Perindopril—Headache—Mitoxantrone—prostate cancer	4.75e-05	0.000183	CcSEcCtD
Perindopril—Hypotension—Capecitabine—prostate cancer	4.74e-05	0.000183	CcSEcCtD
Perindopril—Insomnia—Docetaxel—prostate cancer	4.74e-05	0.000183	CcSEcCtD
Perindopril—Arthralgia—Prednisone—prostate cancer	4.71e-05	0.000182	CcSEcCtD
Perindopril—Myalgia—Prednisone—prostate cancer	4.71e-05	0.000182	CcSEcCtD
Perindopril—Paraesthesia—Docetaxel—prostate cancer	4.7e-05	0.000182	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—prostate cancer	4.7e-05	0.000182	CcSEcCtD
Perindopril—Anxiety—Prednisone—prostate cancer	4.7e-05	0.000181	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—prostate cancer	4.69e-05	0.000181	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.68e-05	0.000181	CcSEcCtD
Perindopril—Dyspnoea—Docetaxel—prostate cancer	4.67e-05	0.00018	CcSEcCtD
Perindopril—Somnolence—Docetaxel—prostate cancer	4.66e-05	0.00018	CcSEcCtD
Perindopril—Discomfort—Prednisone—prostate cancer	4.66e-05	0.00018	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—prostate cancer	4.65e-05	0.00018	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—prostate cancer	4.64e-05	0.000179	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—prostate cancer	4.63e-05	0.000179	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.62e-05	0.000179	CcSEcCtD
Perindopril—Flushing—Epirubicin—prostate cancer	4.62e-05	0.000178	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—prostate cancer	4.62e-05	0.000178	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—prostate cancer	4.61e-05	0.000178	CcSEcCtD
Perindopril—Dyspepsia—Docetaxel—prostate cancer	4.61e-05	0.000178	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—prostate cancer	4.6e-05	0.000178	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—prostate cancer	4.6e-05	0.000178	CcSEcCtD
Perindopril—Insomnia—Capecitabine—prostate cancer	4.59e-05	0.000177	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—prostate cancer	4.57e-05	0.000176	CcSEcCtD
Perindopril—Paraesthesia—Capecitabine—prostate cancer	4.55e-05	0.000176	CcSEcCtD
Perindopril—Decreased appetite—Docetaxel—prostate cancer	4.55e-05	0.000176	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—prostate cancer	4.55e-05	0.000176	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—prostate cancer	4.53e-05	0.000175	CcSEcCtD
Perindopril—Gastrointestinal disorder—Docetaxel—prostate cancer	4.52e-05	0.000175	CcSEcCtD
Perindopril—Asthenia—Etoposide—prostate cancer	4.52e-05	0.000175	CcSEcCtD
Perindopril—Dyspnoea—Capecitabine—prostate cancer	4.52e-05	0.000175	CcSEcCtD
Perindopril—Anaphylactic shock—Prednisone—prostate cancer	4.52e-05	0.000175	CcSEcCtD
Perindopril—Oedema—Prednisone—prostate cancer	4.52e-05	0.000175	CcSEcCtD
Perindopril—Fatigue—Docetaxel—prostate cancer	4.52e-05	0.000175	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—prostate cancer	4.51e-05	0.000174	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—prostate cancer	4.51e-05	0.000174	CcSEcCtD
Perindopril—Nausea—Mitoxantrone—prostate cancer	4.5e-05	0.000174	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—prostate cancer	4.48e-05	0.000173	CcSEcCtD
Perindopril—Pain—Docetaxel—prostate cancer	4.48e-05	0.000173	CcSEcCtD
Perindopril—Constipation—Docetaxel—prostate cancer	4.48e-05	0.000173	CcSEcCtD
Perindopril—Dyspepsia—Capecitabine—prostate cancer	4.47e-05	0.000173	CcSEcCtD
Perindopril—Chills—Epirubicin—prostate cancer	4.46e-05	0.000172	CcSEcCtD
Perindopril—Pruritus—Etoposide—prostate cancer	4.46e-05	0.000172	CcSEcCtD
Perindopril—Shock—Prednisone—prostate cancer	4.45e-05	0.000172	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—prostate cancer	4.44e-05	0.000172	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—prostate cancer	4.44e-05	0.000171	CcSEcCtD
Perindopril—Nervous system disorder—Prednisone—prostate cancer	4.43e-05	0.000171	CcSEcCtD
Perindopril—Tachycardia—Prednisone—prostate cancer	4.41e-05	0.00017	CcSEcCtD
Perindopril—Decreased appetite—Capecitabine—prostate cancer	4.41e-05	0.00017	CcSEcCtD
Perindopril—Alopecia—Epirubicin—prostate cancer	4.4e-05	0.00017	CcSEcCtD
Perindopril—Skin disorder—Prednisone—prostate cancer	4.39e-05	0.00017	CcSEcCtD
Perindopril—Gastrointestinal disorder—Capecitabine—prostate cancer	4.38e-05	0.000169	CcSEcCtD
Perindopril—Fatigue—Capecitabine—prostate cancer	4.37e-05	0.000169	CcSEcCtD
Perindopril—Hyperhidrosis—Prednisone—prostate cancer	4.37e-05	0.000169	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—prostate cancer	4.36e-05	0.000168	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—prostate cancer	4.35e-05	0.000168	CcSEcCtD
Perindopril—Constipation—Capecitabine—prostate cancer	4.34e-05	0.000168	CcSEcCtD
Perindopril—Pain—Capecitabine—prostate cancer	4.34e-05	0.000168	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—prostate cancer	4.33e-05	0.000167	CcSEcCtD
Perindopril—Erythema—Epirubicin—prostate cancer	4.33e-05	0.000167	CcSEcCtD
Perindopril—Feeling abnormal—Docetaxel—prostate cancer	4.32e-05	0.000167	CcSEcCtD
Perindopril—Diarrhoea—Etoposide—prostate cancer	4.31e-05	0.000167	CcSEcCtD
Perindopril—Anorexia—Prednisone—prostate cancer	4.31e-05	0.000166	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—prostate cancer	4.3e-05	0.000166	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—prostate cancer	4.29e-05	0.000166	CcSEcCtD
Perindopril—Gastrointestinal pain—Docetaxel—prostate cancer	4.28e-05	0.000166	CcSEcCtD
Perindopril—Flushing—Doxorubicin—prostate cancer	4.27e-05	0.000165	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—prostate cancer	4.27e-05	0.000165	CcSEcCtD
Perindopril—Flatulence—Epirubicin—prostate cancer	4.27e-05	0.000165	CcSEcCtD
Perindopril—Tension—Epirubicin—prostate cancer	4.25e-05	0.000164	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—prostate cancer	4.24e-05	0.000164	CcSEcCtD
Perindopril—Nervousness—Epirubicin—prostate cancer	4.21e-05	0.000162	CcSEcCtD
Perindopril—Back pain—Epirubicin—prostate cancer	4.19e-05	0.000162	CcSEcCtD
Perindopril—Feeling abnormal—Capecitabine—prostate cancer	4.18e-05	0.000162	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—prostate cancer	4.18e-05	0.000161	CcSEcCtD
Perindopril—Dizziness—Etoposide—prostate cancer	4.17e-05	0.000161	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—prostate cancer	4.16e-05	0.000161	CcSEcCtD
Perindopril—Gastrointestinal pain—Capecitabine—prostate cancer	4.15e-05	0.00016	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—prostate cancer	4.15e-05	0.00016	CcSEcCtD
Perindopril—Abdominal pain—Docetaxel—prostate cancer	4.14e-05	0.00016	CcSEcCtD
Perindopril—Body temperature increased—Docetaxel—prostate cancer	4.14e-05	0.00016	CcSEcCtD
Perindopril—Chills—Doxorubicin—prostate cancer	4.13e-05	0.00016	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Prednisone—prostate cancer	4.12e-05	0.000159	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—prostate cancer	4.11e-05	0.000159	CcSEcCtD
Perindopril—Insomnia—Prednisone—prostate cancer	4.09e-05	0.000158	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—prostate cancer	4.07e-05	0.000157	CcSEcCtD
Perindopril—Paraesthesia—Prednisone—prostate cancer	4.06e-05	0.000157	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—prostate cancer	4.03e-05	0.000156	CcSEcCtD
Perindopril—Urticaria—Capecitabine—prostate cancer	4.03e-05	0.000156	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—prostate cancer	4.02e-05	0.000155	CcSEcCtD
Perindopril—Abdominal pain—Capecitabine—prostate cancer	4.01e-05	0.000155	CcSEcCtD
Perindopril—Body temperature increased—Capecitabine—prostate cancer	4.01e-05	0.000155	CcSEcCtD
Perindopril—Vomiting—Etoposide—prostate cancer	4.01e-05	0.000155	CcSEcCtD
Perindopril—Erythema—Doxorubicin—prostate cancer	4.01e-05	0.000155	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—prostate cancer	4.01e-05	0.000155	CcSEcCtD
Perindopril—Anaemia—Epirubicin—prostate cancer	4e-05	0.000155	CcSEcCtD
Perindopril—Agitation—Epirubicin—prostate cancer	3.98e-05	0.000154	CcSEcCtD
Perindopril—Dyspepsia—Prednisone—prostate cancer	3.98e-05	0.000154	CcSEcCtD
Perindopril—Rash—Etoposide—prostate cancer	3.97e-05	0.000154	CcSEcCtD
Perindopril—Dermatitis—Etoposide—prostate cancer	3.97e-05	0.000153	CcSEcCtD
Perindopril—Headache—Etoposide—prostate cancer	3.95e-05	0.000153	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—prostate cancer	3.95e-05	0.000153	CcSEcCtD
Perindopril—Tension—Doxorubicin—prostate cancer	3.93e-05	0.000152	CcSEcCtD
Perindopril—Decreased appetite—Prednisone—prostate cancer	3.93e-05	0.000152	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—prostate cancer	3.92e-05	0.000152	CcSEcCtD
Perindopril—Malaise—Epirubicin—prostate cancer	3.9e-05	0.000151	CcSEcCtD
Perindopril—Fatigue—Prednisone—prostate cancer	3.9e-05	0.000151	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—prostate cancer	3.89e-05	0.00015	CcSEcCtD
Perindopril—Vertigo—Epirubicin—prostate cancer	3.89e-05	0.00015	CcSEcCtD
Perindopril—Syncope—Epirubicin—prostate cancer	3.88e-05	0.00015	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—prostate cancer	3.88e-05	0.00015	CcSEcCtD
Perindopril—Back pain—Doxorubicin—prostate cancer	3.88e-05	0.00015	CcSEcCtD
Perindopril—Constipation—Prednisone—prostate cancer	3.86e-05	0.000149	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—prostate cancer	3.85e-05	0.000149	CcSEcCtD
Perindopril—Palpitations—Epirubicin—prostate cancer	3.83e-05	0.000148	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—prostate cancer	3.81e-05	0.000147	CcSEcCtD
Perindopril—Cough—Epirubicin—prostate cancer	3.78e-05	0.000146	CcSEcCtD
Perindopril—Asthenia—Docetaxel—prostate cancer	3.76e-05	0.000145	CcSEcCtD
Perindopril—Nausea—Etoposide—prostate cancer	3.74e-05	0.000145	CcSEcCtD
Perindopril—Hypertension—Epirubicin—prostate cancer	3.74e-05	0.000144	CcSEcCtD
Perindopril—Feeling abnormal—Prednisone—prostate cancer	3.72e-05	0.000144	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—prostate cancer	3.72e-05	0.000144	CcSEcCtD
Perindopril—Pruritus—Docetaxel—prostate cancer	3.71e-05	0.000143	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—prostate cancer	3.7e-05	0.000143	CcSEcCtD
Perindopril—Gastrointestinal pain—Prednisone—prostate cancer	3.69e-05	0.000143	CcSEcCtD
Perindopril—Chest pain—Epirubicin—prostate cancer	3.69e-05	0.000142	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—prostate cancer	3.69e-05	0.000142	CcSEcCtD
Perindopril—Myalgia—Epirubicin—prostate cancer	3.69e-05	0.000142	CcSEcCtD
Perindopril—Agitation—Doxorubicin—prostate cancer	3.68e-05	0.000142	CcSEcCtD
Perindopril—Anxiety—Epirubicin—prostate cancer	3.67e-05	0.000142	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.66e-05	0.000141	CcSEcCtD
Perindopril—Discomfort—Epirubicin—prostate cancer	3.64e-05	0.000141	CcSEcCtD
Perindopril—Asthenia—Capecitabine—prostate cancer	3.64e-05	0.000141	CcSEcCtD
Perindopril—Malaise—Doxorubicin—prostate cancer	3.61e-05	0.00014	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—prostate cancer	3.61e-05	0.000139	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—prostate cancer	3.6e-05	0.000139	CcSEcCtD
Perindopril—Syncope—Doxorubicin—prostate cancer	3.59e-05	0.000139	CcSEcCtD
Perindopril—Urticaria—Prednisone—prostate cancer	3.59e-05	0.000139	CcSEcCtD
Perindopril—Pruritus—Capecitabine—prostate cancer	3.59e-05	0.000139	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—prostate cancer	3.59e-05	0.000139	CcSEcCtD
Perindopril—Diarrhoea—Docetaxel—prostate cancer	3.58e-05	0.000139	CcSEcCtD
Perindopril—Body temperature increased—Prednisone—prostate cancer	3.57e-05	0.000138	CcSEcCtD
Perindopril—Abdominal pain—Prednisone—prostate cancer	3.57e-05	0.000138	CcSEcCtD
Perindopril—Confusional state—Epirubicin—prostate cancer	3.56e-05	0.000138	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—prostate cancer	3.54e-05	0.000137	CcSEcCtD
Perindopril—Oedema—Epirubicin—prostate cancer	3.53e-05	0.000137	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—prostate cancer	3.53e-05	0.000137	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—prostate cancer	3.52e-05	0.000136	CcSEcCtD
Perindopril—Cough—Doxorubicin—prostate cancer	3.5e-05	0.000135	CcSEcCtD
Perindopril—Shock—Epirubicin—prostate cancer	3.48e-05	0.000134	CcSEcCtD
Perindopril—Diarrhoea—Capecitabine—prostate cancer	3.47e-05	0.000134	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—prostate cancer	3.47e-05	0.000134	CcSEcCtD
Perindopril—Dizziness—Docetaxel—prostate cancer	3.46e-05	0.000134	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—prostate cancer	3.46e-05	0.000134	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—prostate cancer	3.46e-05	0.000134	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—prostate cancer	3.45e-05	0.000133	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—prostate cancer	3.43e-05	0.000133	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—prostate cancer	3.42e-05	0.000132	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—prostate cancer	3.41e-05	0.000132	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—prostate cancer	3.41e-05	0.000132	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—prostate cancer	3.41e-05	0.000132	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—prostate cancer	3.4e-05	0.000131	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.39e-05	0.000131	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—prostate cancer	3.37e-05	0.00013	CcSEcCtD
Perindopril—Anorexia—Epirubicin—prostate cancer	3.37e-05	0.00013	CcSEcCtD
Perindopril—Dizziness—Capecitabine—prostate cancer	3.35e-05	0.00013	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—prostate cancer	3.34e-05	0.000129	CcSEcCtD
Perindopril—Vomiting—Docetaxel—prostate cancer	3.33e-05	0.000129	CcSEcCtD
Perindopril—Rash—Docetaxel—prostate cancer	3.3e-05	0.000128	CcSEcCtD
Perindopril—Hypotension—Epirubicin—prostate cancer	3.3e-05	0.000128	CcSEcCtD
Perindopril—Dermatitis—Docetaxel—prostate cancer	3.3e-05	0.000128	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—prostate cancer	3.3e-05	0.000127	CcSEcCtD
Perindopril—Headache—Docetaxel—prostate cancer	3.28e-05	0.000127	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—prostate cancer	3.27e-05	0.000126	CcSEcCtD
Perindopril—Oedema—Doxorubicin—prostate cancer	3.27e-05	0.000126	CcSEcCtD
Perindopril—Asthenia—Prednisone—prostate cancer	3.24e-05	0.000125	CcSEcCtD
Perindopril—Vomiting—Capecitabine—prostate cancer	3.23e-05	0.000125	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.22e-05	0.000124	CcSEcCtD
Perindopril—Shock—Doxorubicin—prostate cancer	3.22e-05	0.000124	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—prostate cancer	3.21e-05	0.000124	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—prostate cancer	3.2e-05	0.000124	CcSEcCtD
Perindopril—Rash—Capecitabine—prostate cancer	3.2e-05	0.000124	CcSEcCtD
Perindopril—Pruritus—Prednisone—prostate cancer	3.2e-05	0.000124	CcSEcCtD
Perindopril—Insomnia—Epirubicin—prostate cancer	3.2e-05	0.000123	CcSEcCtD
Perindopril—Dermatitis—Capecitabine—prostate cancer	3.2e-05	0.000123	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—prostate cancer	3.19e-05	0.000123	CcSEcCtD
Perindopril—Headache—Capecitabine—prostate cancer	3.18e-05	0.000123	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—prostate cancer	3.18e-05	0.000123	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—prostate cancer	3.17e-05	0.000123	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—prostate cancer	3.16e-05	0.000122	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—prostate cancer	3.15e-05	0.000122	CcSEcCtD
Perindopril—Somnolence—Epirubicin—prostate cancer	3.14e-05	0.000121	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—prostate cancer	3.12e-05	0.00012	CcSEcCtD
Perindopril—Nausea—Docetaxel—prostate cancer	3.11e-05	0.00012	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—prostate cancer	3.11e-05	0.00012	CcSEcCtD
Perindopril—Diarrhoea—Prednisone—prostate cancer	3.09e-05	0.000119	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—prostate cancer	3.07e-05	0.000119	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—prostate cancer	3.06e-05	0.000118	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—prostate cancer	3.05e-05	0.000118	CcSEcCtD
Perindopril—Fatigue—Epirubicin—prostate cancer	3.05e-05	0.000118	CcSEcCtD
Perindopril—Constipation—Epirubicin—prostate cancer	3.02e-05	0.000117	CcSEcCtD
Perindopril—Pain—Epirubicin—prostate cancer	3.02e-05	0.000117	CcSEcCtD
Perindopril—Nausea—Capecitabine—prostate cancer	3.01e-05	0.000116	CcSEcCtD
Perindopril—Dizziness—Prednisone—prostate cancer	2.99e-05	0.000115	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.98e-05	0.000115	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—prostate cancer	2.96e-05	0.000114	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—prostate cancer	2.94e-05	0.000113	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—prostate cancer	2.92e-05	0.000113	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—prostate cancer	2.91e-05	0.000113	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—prostate cancer	2.91e-05	0.000112	CcSEcCtD
Perindopril—BCHE—Metabolism—HSD17B3—prostate cancer	2.9e-05	0.000527	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ACSL4—prostate cancer	2.9e-05	0.000527	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.9e-05	0.000527	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HAO1—prostate cancer	2.9e-05	0.000527	CbGpPWpGaD
Perindopril—Gastrointestinal pain—Epirubicin—prostate cancer	2.89e-05	0.000112	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	2.88e-05	0.000524	CbGpPWpGaD
Perindopril—Dyspepsia—Doxorubicin—prostate cancer	2.88e-05	0.000111	CcSEcCtD
Perindopril—Vomiting—Prednisone—prostate cancer	2.87e-05	0.000111	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—CXCL8—prostate cancer	2.87e-05	0.000521	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.86e-05	0.000521	CbGpPWpGaD
Perindopril—Rash—Prednisone—prostate cancer	2.85e-05	0.00011	CcSEcCtD
Perindopril—Dermatitis—Prednisone—prostate cancer	2.85e-05	0.00011	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—prostate cancer	2.84e-05	0.00011	CcSEcCtD
Perindopril—Headache—Prednisone—prostate cancer	2.83e-05	0.000109	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.82e-05	0.000109	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—prostate cancer	2.82e-05	0.000109	CcSEcCtD
Perindopril—Urticaria—Epirubicin—prostate cancer	2.81e-05	0.000108	CcSEcCtD
Perindopril—Constipation—Doxorubicin—prostate cancer	2.8e-05	0.000108	CcSEcCtD
Perindopril—Pain—Doxorubicin—prostate cancer	2.8e-05	0.000108	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—prostate cancer	2.79e-05	0.000108	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—prostate cancer	2.79e-05	0.000108	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—ACE—prostate cancer	2.79e-05	0.000507	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PHGDH—prostate cancer	2.78e-05	0.000505	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ARG2—prostate cancer	2.78e-05	0.000505	CbGpPWpGaD
Perindopril—BCHE—Metabolism—UMPS—prostate cancer	2.78e-05	0.000505	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.77e-05	0.000504	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.76e-05	0.000503	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LDHB—prostate cancer	2.72e-05	0.000495	CbGpPWpGaD
Perindopril—Feeling abnormal—Doxorubicin—prostate cancer	2.69e-05	0.000104	CcSEcCtD
Perindopril—Nausea—Prednisone—prostate cancer	2.68e-05	0.000104	CcSEcCtD
Perindopril—BCHE—Metabolism—CYP3A5—prostate cancer	2.67e-05	0.000486	CbGpPWpGaD
Perindopril—Gastrointestinal pain—Doxorubicin—prostate cancer	2.67e-05	0.000103	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	2.65e-05	0.000481	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CTNNB1—prostate cancer	2.65e-05	0.000481	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CA—prostate cancer	2.62e-05	0.000477	CbGpPWpGaD
Perindopril—Urticaria—Doxorubicin—prostate cancer	2.6e-05	0.0001	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—prostate cancer	2.58e-05	9.99e-05	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—prostate cancer	2.58e-05	9.99e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—PDHA1—prostate cancer	2.58e-05	0.00047	CbGpPWpGaD
Perindopril—BCHE—Metabolism—UCP3—prostate cancer	2.58e-05	0.00047	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA3—prostate cancer	2.58e-05	0.00047	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TCN2—prostate cancer	2.58e-05	0.00047	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.57e-05	0.000467	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—prostate cancer	2.56e-05	0.000466	CbGpPWpGaD
Perindopril—Asthenia—Epirubicin—prostate cancer	2.54e-05	9.8e-05	CcSEcCtD
Perindopril—BCHE—Neuronal System—MDM2—prostate cancer	2.52e-05	0.000458	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—PLAUR—prostate cancer	2.5e-05	0.000455	CbGpPWpGaD
Perindopril—Pruritus—Epirubicin—prostate cancer	2.5e-05	9.66e-05	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.48e-05	0.000451	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC22A3—prostate cancer	2.46e-05	0.000448	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HSD3B1—prostate cancer	2.46e-05	0.000448	CbGpPWpGaD
Perindopril—Diarrhoea—Epirubicin—prostate cancer	2.42e-05	9.34e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.39e-05	0.000435	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.37e-05	0.000431	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TBXAS1—prostate cancer	2.36e-05	0.00043	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA4—prostate cancer	2.36e-05	0.00043	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CBR1—prostate cancer	2.36e-05	0.000429	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PSAT1—prostate cancer	2.36e-05	0.000429	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GRHL1—prostate cancer	2.36e-05	0.000429	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TST—prostate cancer	2.36e-05	0.000429	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CSAD—prostate cancer	2.36e-05	0.000429	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ADI1—prostate cancer	2.36e-05	0.000429	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—TGFB1—prostate cancer	2.35e-05	0.000427	CbGpPWpGaD
Perindopril—Asthenia—Doxorubicin—prostate cancer	2.35e-05	9.06e-05	CcSEcCtD
Perindopril—Dizziness—Epirubicin—prostate cancer	2.34e-05	9.03e-05	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—prostate cancer	2.31e-05	8.94e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.31e-05	0.00042	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA2—prostate cancer	2.3e-05	0.000419	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.3e-05	0.000418	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SULT1A1—prostate cancer	2.27e-05	0.000414	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCG5—prostate cancer	2.27e-05	0.000414	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	2.25e-05	0.00041	CbGpPWpGaD
Perindopril—Vomiting—Epirubicin—prostate cancer	2.25e-05	8.68e-05	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—prostate cancer	2.24e-05	8.64e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	2.24e-05	0.000407	CbGpPWpGaD
Perindopril—Rash—Epirubicin—prostate cancer	2.23e-05	8.61e-05	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—prostate cancer	2.23e-05	8.6e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—GSTA1—prostate cancer	2.22e-05	0.000404	CbGpPWpGaD
Perindopril—Headache—Epirubicin—prostate cancer	2.21e-05	8.55e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—NAT2—prostate cancer	2.2e-05	0.000399	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HSD3B2—prostate cancer	2.2e-05	0.000399	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTO1—prostate cancer	2.2e-05	0.000399	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UGT2B17—prostate cancer	2.19e-05	0.000399	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GRHPR—prostate cancer	2.19e-05	0.000399	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CKMT2—prostate cancer	2.19e-05	0.000399	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UGT2B15—prostate cancer	2.19e-05	0.000399	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	2.18e-05	0.000397	CbGpPWpGaD
Perindopril—Dizziness—Doxorubicin—prostate cancer	2.16e-05	8.35e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	2.11e-05	0.000384	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.11e-05	0.000384	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2C18—prostate cancer	2.11e-05	0.000383	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LRP2—prostate cancer	2.11e-05	0.000383	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PLCB2—prostate cancer	2.11e-05	0.000383	CbGpPWpGaD
Perindopril—Nausea—Epirubicin—prostate cancer	2.1e-05	8.11e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	2.09e-05	0.000381	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	2.09e-05	0.00038	CbGpPWpGaD
Perindopril—Vomiting—Doxorubicin—prostate cancer	2.08e-05	8.03e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—P4HB—prostate cancer	2.07e-05	0.000376	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NAGLU—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AOX1—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SULT2B1—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTM3—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PGAM2—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MBTPS1—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—RFK—prostate cancer	2.06e-05	0.000375	CbGpPWpGaD
Perindopril—Rash—Doxorubicin—prostate cancer	2.06e-05	7.97e-05	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—prostate cancer	2.06e-05	7.96e-05	CcSEcCtD
Perindopril—Headache—Doxorubicin—prostate cancer	2.05e-05	7.91e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—SLC22A1—prostate cancer	2.01e-05	0.000365	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.99e-05	0.000362	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.99e-05	0.000361	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SULT2A1—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP3A43—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SRD5A2—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—DEGS1—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NAT1—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AMACR—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Perindopril—Nausea—Doxorubicin—prostate cancer	1.94e-05	7.5e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.93e-05	0.000352	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MED12—prostate cancer	1.93e-05	0.00035	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GNG5—prostate cancer	1.91e-05	0.000347	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.89e-05	0.000343	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.87e-05	0.00034	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD17B1—prostate cancer	1.87e-05	0.000339	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOA3—prostate cancer	1.84e-05	0.000335	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.81e-05	0.000329	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.78e-05	0.000323	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HPGDS—prostate cancer	1.76e-05	0.000319	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2C19—prostate cancer	1.74e-05	0.000317	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—LEP—prostate cancer	1.73e-05	0.000315	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ACHE—prostate cancer	1.7e-05	0.00031	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTT1—prostate cancer	1.7e-05	0.00031	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.7e-05	0.000309	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.69e-05	0.000307	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2A6—prostate cancer	1.68e-05	0.000306	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.68e-05	0.000305	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.66e-05	0.000303	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HPGD—prostate cancer	1.66e-05	0.000302	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—B4GALT4—prostate cancer	1.66e-05	0.000302	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.64e-05	0.000298	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKR1C3—prostate cancer	1.64e-05	0.000298	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PRKACB—prostate cancer	1.63e-05	0.000296	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP17A1—prostate cancer	1.61e-05	0.000293	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.6e-05	0.000292	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.6e-05	0.000291	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.59e-05	0.000289	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.56e-05	0.000284	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOA2—prostate cancer	1.54e-05	0.000279	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.53e-05	0.000278	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP7B1—prostate cancer	1.52e-05	0.000277	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTAP—prostate cancer	1.52e-05	0.000277	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.52e-05	0.000276	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.49e-05	0.000271	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SULT1E1—prostate cancer	1.48e-05	0.00027	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SRD5A1—prostate cancer	1.48e-05	0.00027	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—INS—prostate cancer	1.48e-05	0.000269	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC5A5—prostate cancer	1.47e-05	0.000266	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.45e-05	0.000264	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.44e-05	0.000261	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2E1—prostate cancer	1.43e-05	0.00026	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGF1—prostate cancer	1.43e-05	0.00026	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NQO1—prostate cancer	1.42e-05	0.000257	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD17B3—prostate cancer	1.41e-05	0.000257	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ACSL4—prostate cancer	1.41e-05	0.000257	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.4e-05	0.000255	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.4e-05	0.000254	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TH—prostate cancer	1.39e-05	0.000254	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.39e-05	0.000252	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MMP2—prostate cancer	1.38e-05	0.000252	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP3A4—prostate cancer	1.38e-05	0.000251	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.37e-05	0.00025	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP1B1—prostate cancer	1.36e-05	0.000247	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PHGDH—prostate cancer	1.36e-05	0.000247	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ARG2—prostate cancer	1.36e-05	0.000247	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UMPS—prostate cancer	1.36e-05	0.000247	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.35e-05	0.000245	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.33e-05	0.000243	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LDHB—prostate cancer	1.33e-05	0.000242	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GGT1—prostate cancer	1.31e-05	0.000239	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP3A5—prostate cancer	1.3e-05	0.000237	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.3e-05	0.000236	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOA1—prostate cancer	1.29e-05	0.000235	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.28e-05	0.000233	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP19A1—prostate cancer	1.28e-05	0.000232	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.26e-05	0.00023	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PDHA1—prostate cancer	1.26e-05	0.000229	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA3—prostate cancer	1.26e-05	0.000229	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TCN2—prostate cancer	1.26e-05	0.000229	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UCP3—prostate cancer	1.26e-05	0.000229	CbGpPWpGaD
Perindopril—BCHE—Metabolism—RXRA—prostate cancer	1.23e-05	0.000224	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD3B1—prostate cancer	1.2e-05	0.000219	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC22A3—prostate cancer	1.2e-05	0.000219	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.2e-05	0.000218	CbGpPWpGaD
Perindopril—BCHE—Metabolism—COMT—prostate cancer	1.19e-05	0.000216	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTP1—prostate cancer	1.18e-05	0.000215	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.16e-05	0.000211	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ITPR1—prostate cancer	1.16e-05	0.000211	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.16e-05	0.000211	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA4—prostate cancer	1.15e-05	0.00021	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TBXAS1—prostate cancer	1.15e-05	0.00021	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CXCL8—prostate cancer	1.15e-05	0.000209	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.14e-05	0.000208	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.14e-05	0.000207	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA2—prostate cancer	1.12e-05	0.000204	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ABCG5—prostate cancer	1.11e-05	0.000202	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SULT1A1—prostate cancer	1.11e-05	0.000202	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TYMS—prostate cancer	1.1e-05	0.0002	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTM1—prostate cancer	1.08e-05	0.000197	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA1—prostate cancer	1.08e-05	0.000197	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.07e-05	0.000195	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD3B2—prostate cancer	1.07e-05	0.000195	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTO1—prostate cancer	1.07e-05	0.000195	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NAT2—prostate cancer	1.07e-05	0.000195	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LPL—prostate cancer	1.06e-05	0.000194	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.06e-05	0.000193	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP1A1—prostate cancer	1.03e-05	0.000187	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PLCB2—prostate cancer	1.03e-05	0.000187	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2C18—prostate cancer	1.03e-05	0.000187	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LRP2—prostate cancer	1.03e-05	0.000187	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ERCC2—prostate cancer	1.02e-05	0.000185	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—P4HB—prostate cancer	1.01e-05	0.000183	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	9.87e-06	0.00018	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC22A1—prostate cancer	9.8e-06	0.000178	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	9.8e-06	0.000178	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MTHFR—prostate cancer	9.59e-06	0.000174	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SULT2A1—prostate cancer	9.55e-06	0.000174	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	9.55e-06	0.000174	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PPARA—prostate cancer	9.41e-06	0.000171	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MED12—prostate cancer	9.4e-06	0.000171	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GNG5—prostate cancer	9.32e-06	0.00017	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOA3—prostate cancer	8.98e-06	0.000163	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CAV1—prostate cancer	8.84e-06	0.000161	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HPGDS—prostate cancer	8.57e-06	0.000156	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2C19—prostate cancer	8.51e-06	0.000155	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.45e-06	0.000154	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ACHE—prostate cancer	8.31e-06	0.000151	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTT1—prostate cancer	8.31e-06	0.000151	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2A6—prostate cancer	8.21e-06	0.000149	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	8.06e-06	0.000147	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CG—prostate cancer	8.05e-06	0.000146	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKR1C3—prostate cancer	7.99e-06	0.000145	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PRKACB—prostate cancer	7.95e-06	0.000145	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP17A1—prostate cancer	7.87e-06	0.000143	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.78e-06	0.000141	CbGpPWpGaD
Perindopril—BCHE—Metabolism—INS—prostate cancer	7.62e-06	0.000139	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOA2—prostate cancer	7.5e-06	0.000136	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CREBBP—prostate cancer	7.47e-06	0.000136	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC5A5—prostate cancer	7.15e-06	0.00013	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CD—prostate cancer	7.08e-06	0.000129	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2E1—prostate cancer	6.98e-06	0.000127	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NQO1—prostate cancer	6.91e-06	0.000126	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TH—prostate cancer	6.81e-06	0.000124	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP3A4—prostate cancer	6.73e-06	0.000122	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NOS3—prostate cancer	6.69e-06	0.000122	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP1B1—prostate cancer	6.62e-06	0.00012	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GGT1—prostate cancer	6.41e-06	0.000117	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOA1—prostate cancer	6.32e-06	0.000115	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP19A1—prostate cancer	6.22e-06	0.000113	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CB—prostate cancer	6.17e-06	0.000112	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTGS2—prostate cancer	6.12e-06	0.000111	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—RXRA—prostate cancer	6.01e-06	0.000109	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—COMT—prostate cancer	5.79e-06	0.000105	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTP1—prostate cancer	5.76e-06	0.000105	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ITPR1—prostate cancer	5.67e-06	0.000103	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TYMS—prostate cancer	5.35e-06	9.74e-05	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTEN—prostate cancer	5.33e-06	9.7e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTM1—prostate cancer	5.29e-06	9.62e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LPL—prostate cancer	5.2e-06	9.45e-05	CbGpPWpGaD
Perindopril—BCHE—Metabolism—EP300—prostate cancer	5.09e-06	9.25e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP1A1—prostate cancer	5.02e-06	9.12e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ERCC2—prostate cancer	4.98e-06	9.05e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTHFR—prostate cancer	4.68e-06	8.51e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PPARA—prostate cancer	4.59e-06	8.34e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CAV1—prostate cancer	4.31e-06	7.85e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CG—prostate cancer	3.93e-06	7.15e-05	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CA—prostate cancer	3.76e-06	6.84e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—INS—prostate cancer	3.72e-06	6.76e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CREBBP—prostate cancer	3.64e-06	6.63e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CD—prostate cancer	3.45e-06	6.28e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NOS3—prostate cancer	3.26e-06	5.93e-05	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKT1—prostate cancer	3.07e-06	5.59e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CB—prostate cancer	3.01e-06	5.48e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTGS2—prostate cancer	2.98e-06	5.43e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTEN—prostate cancer	2.6e-06	4.73e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—EP300—prostate cancer	2.48e-06	4.51e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CA—prostate cancer	1.84e-06	3.34e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKT1—prostate cancer	1.5e-06	2.73e-05	CbGpPWpGaD
